BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
20 hedge funds and large institutions have $352K invested in Baudax Bio, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$96.4K | |
| 2 | +$57.6K | |
| 3 | +$21.9K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$17.2K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$12K |
Top Sellers
| 1 | -$389K | |
| 2 | -$165K | |
| 3 | -$19.3K | |
| 4 |
HF
HRT Financial
New York
|
-$19K |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$3K |